Neuron- and glia-like cells derived from induced pluripotent stem cells promise tractable, individualized human models of Alzheimer's, Parkinson's and amyotrophic lateral sclerosis. Ken Garber explores the considerable challenges of recreating such diseases in the laboratory.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Donnelly, C.J. et al. Neuron 80, 415–428 (2013).
Sareen, D. et al. Sci. Transl. Med. 5, 280ra149 (2013).
Cooper, O. et al. Sci. Transl. Med. 4, 141ra90 (2012).
Sanders, L.H. et al. Neurobiol. Dis. 62, 381–386 (2014).
Miller, J.D. et al. Cell Stem Cell 13, 691–705 (2013).
Israel, M.A. et al. Nature 482, 216–220 (2012).
Shi, Y. et al. Sci. Transl. Med. 4, 124ra29 (2012).
Griswold-Prenner, I. et al. Abstract 598, presented at the annual meeting of the Society for Neuroscience, San Diego, November 9–13, 2013.
Kondo, T. et al. Cell Stem Cell 12, 487–496 (2013).
Duan, L. et al. Mol. Neurodegener. 9, 3 (2014).
Qiang, L. et al. Cell 157, 514 (2014).
Zhang, Y. et al. Neuron 78, 785–798 (2013).
Chambers, S.M. et al. Nat. Biotechnol. 30, 715–720 (2012).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Garber, K. Between disease and a dish. Nat Biotechnol 32, 712–715 (2014). https://doi.org/10.1038/nbt.2977
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt.2977
This article is cited by
-
A bioprinted human-glioblastoma-on-a-chip for the identification of patient-specific responses to chemoradiotherapy
Nature Biomedical Engineering (2019)
